2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z

M-CSF and TNF-α Induce Human MDSCs That Attenuate GVHD

F. Han, C. Ding, Y. Zhao, P. Tian.
Machine Learning to Assess Kidney Donor Risk

A. Shah, M. Li, Z. Chen.
Macrophage Depletion of RCMV-Latently Infected Allografts Ameliorates Accelerated Chronic Cardiac Rejection

J. Burg,¹ N. Haese,² T. Andoh,² C. Kreklywich,² I. Jones,² S. Orloff,¹ D. Streblow.²
Magnitude of Pre-Biopsy Decline in Renal Function and Its Association with Allograft Rejection

S. Voora,¹ P. Ahearn,¹ M. Tavakol,² K. Johansen,^1,3 E. Ku.¹
Maintenance Immunosuppression Trends in Hand and Facial VCA Transplantation

A. Manjunath,¹ M. Cammarata,¹ R. Kantar,¹ W. Rifkin,¹ A. Jacoby,¹ B. Gelb,² R. Diaz-Siso,¹ E. Rodriguez.¹
Major Adverse Cardiovascular Events Following Simultaneous Pancreas and Kidney Transplantation. A Study of the United Kingdom Transplant Registry

P. Yiannoullou,^1,2 A. Summers,^1,2 C. Fullwood,² Z. Moinuddin,^1,2 I. Shapey,^1,2 H. Khambalia,^1,2 T. Augustine,^1,2 M. Rutter,^1,2 D. van Dellen.^1,2
Making Right Donor Nephrectomy Great Again: Evaluating Right Hand Assisted Retroperitoneal Donor Nephrectomy

H. Alahdal,¹ F. Alghamdi,¹ M. Shoukri,² J. Brockmann,¹ D. Broering.¹
Making Sense of Hepatitis B Reactivation Risk in Anti-HBc Antibody (Ab) Positive Liver Transplant Recipients

S. Leistman,¹ J. Melaragno,¹ M. Dokus,² B. Al-Judaibi,² T. Babu.³
Malignancies in Kidney Transplant Recipients: A Long-Term Observational Study

D. Khadzhynov, F. Halleck, F. Froehlich, L. Lehner, E. Schrezenmeyer, K. Budde, O. Staeck.
Malignancy Complications after Kidney Transplantation, the Role of Immunosuppression

M. Molina,¹ J. Cabrera,² E. Gonzalez,¹ A. Hernández,¹ N. Polanco,¹ A. Andres.¹
Many Highly Sensitized Candidates Still Waiting for Transplant Despite the Kidney Allocation System Change: Making the Case for Incompatible Transplantation

C. Schinstock, B. Smith, A. Bentall, M. Stegall.
Marijuana Use Should Not Preclude Consideration for Kidney Transplantation

K. Fabbri, T. Anderson-Haag, A. Spenningsby, A. Israni, R. Nygaard, P. Stahler.
Maternal and Fetal Outcomes in Living Kidney Donors in Korea

H. Lee,¹ K. Yoo,² M. Yu,¹ Y. Kim.¹
Maximizing Utilization in Pancreas Transplantation: Phenotypic CharacteristicsDifferentiating Aggressive from Nonaggressive Transplant Centers

O. K. Serrano,¹ D. M. Vock,² T. B. Dunn,¹ R. Kandaswamy,¹ E. B. Finger.¹
Mayo Clinic's First Face Transplant: 17 Months On

H. Amer, S. Jowsey-Gregoire, C. Rosen, R. Razonable, K. Reid, M. Gandhi, L. Ewoldt, B. Edwards, S. Mardini.
MCS and Desensitization

J. Kobashigawa, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, E. Passano, L. Czer, J. Moriguchi, F. Arabia.
Measles and Varicella Vaccination Status and Evidence of Immunity during Solid Organ Pre-Transplantation Evaluation

H. Daniels, C. Saracusa, S. Worley, B. Gonzalez.
Measures of Physical Frailty, Cardiac Function and Cardiac Biomarkers among Kidney Transplant Candidates

S. Gilligan,¹ S. Anand,² D. Morris,² M. Minder,¹ T. Srinivas.²
Measuring and Monitoring Equity in Access to Deceased Donor Liver Transplants

D. Stewart, A. Robinson, A. Harper, D. Klassen.
Mechanisms of DEPTOR Function in CD4⁺ T Cell Subsets

J. Wedel,¹ K. Liu,¹ P. Sage,² M. Laplante,³ D. Briscoe.¹
Mechanisms of Vascularized Bone Marrow Graft Protection of Vascularized Composite Allografts

E. Buckingham, N. Shockcor, W. Hassanein, C. Drachenberg, A. Nam, S. Bartlett, R. Barth.
Medical and Psychosocial Outcomes of Directed and Non Directed Living Liver Donors

J. Steel, S. Ganesh, A. Lai, S. Shen, N. Zharichenko, S. Nawaz, K. Kingsley, M. Dulovich, A. Tevar, C. Hughes, A. Humar.
Medical Contraindications to Solid Organ Transplant Listing: A Survey of Heart, Liver, Lung and Kidney Programs

A. Wall, G. Lee, J. Maldonado, D. Magnus.
Medical Crowdfunding for Organ Transplant Patients

W. Durand,¹ J. Peters,¹ A. Eltorai,¹ S. Kalagara,¹ A. Osband,² A. Daniels.³
Medicare Part D Plans Deny Coverage for Off-Label and Off-Compendia Immunosuppressant Use: A Case Series

L. Potter, E. Garrity.
Medication Adherence: Does Where You Live Matter?

S. Wadhwani,¹ S. Taylor,¹ C. Brokamp,¹ W. Guo,¹ E. Shemesh,² J. Bucuvalas.¹
Medication Reconciliation in Abdominal Transplantation

S. Todd,¹ J. Perryman,² R. Subramanian,² A. Patel,² M. Hawthorne,² R. Buenvenida,² K. Lee,² W. Allison,² D. Lo,² P. Reshamwala.²
Medullary Tissue Sampling in Renal Allograft Biopsy is More Sensitive for Pathologic Diagnosis of PVN

D. Abdelwahab,¹ H. Khamash,¹ S. Kriegshauser,³ R. Heilman,¹ M. Smith.²
Meeting OPTN Requirements for Living Kidney Donation Follow-Up: Findings from the KDOC Study

J. Rodrigue,¹ C. Sokas,¹ A. Fleishman,¹ J. Schold,² P. Morrissey,³ J. Whiting,⁴ J. Vella,⁴ L. Kayler,⁵ D. Katz,⁶ J. Jones,⁶ B. Kaplan,⁷ M. Pavlakis,¹ D. Mandelbrot.⁸
Melatonin Prolongs Heart Allograft Survival by Induction of Foxp3+ Regulatory T Cells

L. Liu, Q. Su, Y. Xiong, Z. Bi, H. Huang, Y. Peng, C. Wang.
MELD Based Allocation Deteriorates Patient Survival without Improving Waiting List Mortality in a Low Donor Area

P. Ritschl, L. Wiering, F. Aigner, M. Biebl, D. Eurich, M. Schmelzle, I. Sauer, K. Kotsch, J. Pratschke, R. Öllinger.
MELD-Na Score Based Liver Allocation: Hyponatremia is No Longer a Risk Factor for Waitlist Mortality

S. Nagai,¹ L. Chau,¹ M. Safwan,¹ R. Schilke,¹ M. Rizzari,¹ K. Collins,¹ A. Yoshida,¹ M. Abouljoud,¹ D. Moonka.²
MeltDose Prolonged-Release Once-Daily Tacrolimus (LCPT) vs. Conventional Tacrolimus Formulations in the Initial Maintenance of De Novo Kideny Transplant Recipients across Europe: STEADY Study

K. Budde,¹ G. Piotti,² C. Procaccianti,³ G. Nicolini,³ S. Geraci,³ D. Surace.³
Memory T Cell Dysfunction after Pregnancy Alloimmunization Prolongs Transplant Survival

P. Porrett,¹ J. Cohen,² R. Xu,¹ E. Lewis,³ M. Elovitz,³ E. Wherry,⁴ D. Sawinski.²
MERTK Mediates Transplant Tolerance via IFN-a Regulation of MDSCs and Tregs

L. Zhang, M. DeBerge, E. Thorp, X. Luo.
Metabolic Acidosis after Kidney Transplantation: Prevalence, Risk Factors and Graft Outcome in a French Cohort

F. Garo, I. Szwarc, G. Mourad, M. Le Quintrec, J-.E. Serre.
Metabolic Complications 10-Years after Kidney Transplant

E. Lorenz, F. Cosio, M. Stegall.
Metabolic Regulation of Neuropeptides Induces Weight Loss and is Linked to Prolongation of Allograft Survival

M. Quante,^1,2 T. Heinbokel,¹ K. Minami,¹ Y. Nian,¹ A. Elkhal,¹ S. Tullius.¹
Metabolic Therapy as a Platform for CTLA4Ig Costimulation Blockade in Preventing Allograft Rejection

C-.H. Cheng,^1,2 C-.F. Lee,^1,2 G. Furtmüller,³ B. Oh,³ C. Patel,¹ Y-.C. Lo,¹ M. Fryer,³ G. Brandacher,³ J. Powell.¹
Metformin Use after Kidney Transplantation: A Safe Option in Carefully Selected Patients

F. Koraishy,¹ L. Vest,¹ Z. Zhang,¹ M. Schnitzler,¹ V. Dharnidharka,² D. Axelrod,³ R. Ouseph,¹ A. Naik,⁴ N. Lam,⁵ H. Randall,¹ T. Alhamad,² D. Segev,³ D. Brennan,³ B. Kasiske,⁶ G. Hess,⁷ K. Lentine.
MICA/B Polymorphisms and the Relationship of the Matching Degree between MICA/B and HLA of Related Donor-Recipient Pairs in Allo-HSCT

Y. Sun, Y. Hao, J. Jin, L. Ding, F. Liang, N. Liu, J. Long, X. Zhao, Y. Xi.
Micafungin Prophylaxis in Liver Transplant Recipients at High Risk for Invasive Fungal Infections

A. Nolan, N. Harriott, K. Startsman.
Microbiology and Outcomes of Febrile Neutropenia Episodes after Kidney Transplant

G. Dube, S. Husain, H. Morris, D. Cohen, S. Mohan.
Mid-Term Outcome of Donor Specific Antibody Positive Deceased Donor Kidney Transplantation with Peri-Transplant Desensitization

K. Osickova,¹ P. Hruba,² J. Slatinska,¹ A. Slavcev,² J. Fronek,² E. Honsova,² O. Viklicky.¹
Midodrine Associated with Increased Mortality on Liver Transplant Waitlist

J. Kalil, M. Hertl, E. Schadde, J. Poirier, N. Alvey, E. Chan.
Minimal Invasive Surgery is Feasible and Safe in Patients with Liver and Kidney Transplant Patients

W. Yin.
Mitigating Risk: Post-Exposure Prophylaxis in Liver Transplant Recipients from Donors with Potential Infectious Exposure

A. Nolan, D. Yarosh, S. Shaikh.
Mitochondrial Autophagy Proteins Bnip3 and Nix Maintain Memory B Cell Survival

S. Kodali,¹ H. Sandoval,¹ M. Chen,² J. Wang.¹
Mitochondrial Membrane Permeability Plays a Critical Role for Endothelial Cell Necroptosis and Cardiac Allograft Rejection

I. Gan, J. Jiang, D. Lian, X. Huang, W. Liu, A. Haig, A. Jevnikar, Z. Zhang.
Mitochondrial Quality Control through PGC-1α in Syngenic Mouse Heart Transplant

A. Cherry,¹ K. Porter,¹ H. Suliman,¹ J. Wang,² M. Mulvihill,² A. Kirk.²
Modifiable Causes of Racial Disparities in Living Donor Kidney Transplant

J. Beaumont,¹ J. Peipert,^1,2 C. Anderson,² A. Paiva,³ M. Robbins,³ A. Waterman.^1,2
Modification of Macrophage Phenotype by the Magnetic Field

M. Kloc,¹ W. Chen,¹ J. Kubiak,^2,3 X. Li,¹ R. Ghobrial,¹ J. Wosik.⁴
modified DFPP Can Eliminate Donor-Reactive IgG Antibody with Preserving Fibrinogen before Kidney Transplantation

D. Iwami,¹ T. Matsumoto,² K. Hotta,¹ M. Ota,² Y. Chiba,² H. Higuchi,¹ N. Shinohara.¹
Modified Protocol for ABO-Incompatible Living Donor Liver Transplantation with Rituximab and Intravenous Immunoglobulin without Plasma Exchange

B-.G. Na, E. Lee, S. Kim, S. Park.
Molecular Analysis of Acute Cellular Rejection in Clinical Face Transplants

T. Win, B. Dyring-Andersen, J. Teague, N. Murakami, A. Chandraker, B. Pomahac, L. Riella, R. Clark.
Molecular Assessment of Post-Transplant Glomerular Disease Comparing to Transplant Glomerulopathy

E. Akalin,¹ M. e Silva,² Y. Bao,¹ V. Bontha,³ M. Ajaimy,¹ V. Mas,³ P. [Oacute] Broin.²
Molecular Assessment of Pre-Implantation Donor Biopsies: Effects of Prolonged Cold Ischemia Time and Development of Delayed Graft Function

E. Akalin,¹ Y. Bao,¹ V. Bontha,² M. e Silva,³ M. Ajaimy,¹ P. [Oacute] Broin,³ V. Mas.²
Molecular Classifiers Can Outperform the Flawed Histologic “Gold Standard” on Which They Are Trained

J. Reeve, P. Halloran.
Molecular Injury and Repair Assessment in Ex Vivo Perfused Swine Heart Transplants

N. Herbers, S. Hatami, P. Dromparis, J. Nagendran, M. Mengel, D. Freed, B. Adam.
Molecular Monitoring for Kidney Allograft Injury Following HLA Incompatible Transplantation

A. Jackson,¹ B. Iglehart,¹ S. Bagnasco,³ N. Desai.²
Molecular Phenotypes of Injury and Rejection in Lung Transplant Transbronchial Biopsies

M. Parkes, K. Halloran, K. Famulski, P. Halloran, The INTERLUNG Study Group.
Molecular Profiling of the Injury-Repair Response in Early Subclinical Inflammation

M. Seifert, D. Della Manna, X. Liu, F. Rosenblum, M. Yanik, E. Yang, J. Pollock, R. Mannon.
Monitoring of Small Bowel Allografts with Kynurenine Serum Levels

M. Stangl,¹ D. Koliogiannis,¹ J. Bucher,¹ M. Guba,¹ D. Abendroth.²
Morbidity Outcomes in Live Kidney Donors in the UK: 15 Year Compartive Cohort Study

N. Krishnan,¹ L. Mumford,³ G. Lipkin,⁴ S. Fletcher,¹ I. Dasgupta,⁵ P. Gill,⁶ R. Ryan,⁷ N. Raymond.⁸
Morphometric and Metabolic Correlates of Frailty in Pancreas Transplant Recipients

R. Parsons, J. Wolosyn, R. Lynch.
Mortality and ESRD in Older Live Kidney Donors with Hypertension

F. Al Ammary,¹ X. Luo,¹ A. Muzaale,¹ A. Massie,¹ D. Brennan,¹ A. Wiseman,² J. Snyder,³ D. Segev.¹
Mortality and Kidney Transplantation Outcomes among Chronic Dialysis Patients Who Are Seropositive for Hepatitis C Virus

D. Sawinski,¹ F. Kimberly,¹ L. Vincent,¹ S. Justine,¹ B. Colleen,¹ C. Jordana,¹ G. David,¹ L. Jayme,² W. Joe,³ R. Peter.¹
Mortality of Live Kidney Donors in the UK: 15 Year Comparative Cohort Study

N. Krishnan,¹ L. Mumford,³ G. Lipkin,⁴ S. Fletcher,¹ I. Gupta,⁵ P. Gill,⁶ R. Ryan,⁷ N. Raymond.⁸
Most Pediatric Transplant Centers Are Underperforming and in Proximity to Higher Volume Centers

T. Nichols, A. Rana, J. Goss.
mRNA Transcript Profiles of 14 Genes in Plasma Exosome Predict Risk for Antibody-Mediated Rejection (ABMR) of Renal Allografts

H. Zhang,¹ E. Huang,² C. Nast,³ J. Kahwaji,² A. Vo,² S. Jordan,² M. Toyoda.¹
mRNA Transcript Profiling of 3 Genes in Renal Allograft Biopsies (Bx) Improves Accuracy of Antibody-Mediated Rejection (ABMR) Diagnosis in Transplant Recipients Desensitized with IVIG+Rituximab+Immunoglobulin G-Degrading Enzyme of Streptococcus Pyogenes (IdeS)

H. Zhang,¹ C. Nast,² J. Doldron,² M. Cheung,² A. Vo,³ S. Jordan,³ M. Toyoda.¹
mTOR Inhibition with Everolimus in De Novo Living Donor Liver Transplantation – 24-Months Results from the H2307 Pivotal Trial

L. Jeng,¹ S. Lee,¹ A. Soin,¹ S. Uemoto,¹ D. Maluf,¹ J. Emond,¹ M. Meier,² J. Kochuparampil,² C. Sips,² S. Kaneko,³ G. Levy.¹
mTOR Inhibitor Based Immunosuppression Regimens Are Not Associated with Lower Risk for BK Infection

R. Daloul,¹ R. Pelletier,² A. Rajab,² G. Bumgardner,² M. Alebrahim,² C. Akateh,³ K. Washburn,² A. El-Hinnawi.²
mTORC2 Deficiency in CD11c⁺dendritic Cells Promotes Acute Kidney Injury

H. Dai,^1,2 A. Watson,¹ D. Fantus,¹ L. Peng,² A. Thomson,¹ N. Rogers.¹
Multi-Center Examination of the Reliability and Validity of the Live Donor Assessment Tool (LDAT) as an Enhancement to the Psychosocial Evaluation of Living Donors

D. LaPointe Rudow,¹ S. Jowsey-Gregoire,² F. Desrosiers,³ J. Trompeta,⁴ LDAT Study Group.¹
Multi-Drug Resistant Urinary Tract Infections Following Renal Transplant: Risk Factors and Patient Outcomes

D. Hooker,¹ K. Gutierrez,² K. Foster,¹ A. Dodson.²
Multi-Organ (M-O) Prioritization of Kidneys: ? Time for Policy Modification

M. Aeder, N. Turgeon.
Multi-Targeting Desensitization Therapy Alters Peripheral B-Cell Homeostasis and Suppresses Recall Alloantibody Responses

I. Kim, G. Wu, N-.N. Chai, A. Klein, S. Jordan.
Multi-Visceral Transplant in an HIV Positive Recipient – One Year Survival

S. Nagaraju, R. Mangus, J. Fridell.
Multicentre Epidemiological Study on Prevalence of Recurrent Glomerular Disease Post-Transplantation in the United Kingdom

R. Aguiar.
Multidisciplinary Approach to Prevention of Cytomegalovirus (CMV) Complications in Kidney and Liver Transplant Recipients

S. Shoham,¹ S. Anderson,² R. Avery,¹ M. Belden,³ L. Boyer,³ W. Cochran,³ N. Desai,¹ M. Holechek,³ E. Kraus,¹ J. Langlee,³ P. Spitz,² K. Marr.¹
Multidisciplinary Transplant Rounds: A Step to Improved Team and Patient Satisfaction

K. Sigafus,¹ E. LaMura,¹ M. Massimiani,¹ C. Chiang,² K. Nicoll,² M. Yoho,³ M. Bleicher,² S. Nazarian.²
Multiparametric MRI for Assessment of Renal Transplant Fibrosis: A Pilot

M. Menon, O. Bane, S. Lewis, R. Khaim, S. Florman, P. Kennedy, S. Hectors, V. Delaney, F. Salem, B. Taouli.
Multiple Factors Contribute to an Expanded Immune Risk Profile in Pre Renal Transplant Candidates

D. DeWolfe,¹ K. McGann,¹ J. Ghofrani,¹ E. Geiger,¹ C. Helzer,¹ S. Kleiboeker,² S. Jost,¹ C. Tan.¹
Multiplexed Immunofluorescence to Investigate the Immune Response to BK Virus in Pediatric Kidney Transplant Recipients

C. Fajardo,¹ P. Grimm,¹ N. Kambham,² G. Nolan,³ N. Samusik,³ J. Maltzman.³
Multivariate Cox Proportional Hazards Model for Estimating Long-Term Risk of Aging Kidney Transplant Recipients

A. Yaldo, I. Bajjoka, X. Han, C. Crombez, M. Abouljoud.
Mycophenolate Monotherapy is Safe and Effective in HLA-Matched Kidney Transplant Recipients

A. Hennes, K. Holdener, W. Burlingham, B. Astor, A. Djamali.
Mycophenolic Acid Reduces BK Polyomavirus Replication in an In Vitro Model of Renal Tubular Epithelial Cells Infection

E. Favi,¹ S. Delbue,² C. Colico,¹ P. Ferrante,² S. Villani,² I. Perna,² N. Mondoni,² A. Giussani,¹ M. Ferraresso.¹
Myeloid Derived Suppressor Cells Are Induced after Transplantation and Home to the Transplanted Kidney

Y. Lee, E. Davila, J. Bromberg, J. Scalea.
Myeloid-Derived Suppressor Cells Suppress with Enhanced Donor Specificity in Donor ECDI-SP Treated Recipients

L. Zhang, J. Wang, Z. Zhang, X. Luo.

Jump to: View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z